Zonisade Suspension
Product Images NDC 52652-8001

3 FDA label images from Azurity Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zonisade (NDC 52652-8001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure of zonisamide, the active ingredient in ZONISADE oral suspension 100 mg/5 mL by Azurity Pharmaceuticals, Inc. The diagram shows the sulfonamide group attached to a benzisoxazole ring system.*
FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
A cumulative distribution plot comparing the percentage reduction in all partial seizure rate between Zonisamide suspension and placebo across different percentages of patients. The y-axis represents the percentage reduction in seizure rate from worsening to improvement, and the x-axis shows the percentage of patients. Zonisamide data are represented by blue circles and placebo by orange diamonds, illustrating greater improvement with Zonisamide.*
FDA Label Image

Zonisade-carton-spl (Zonisade Carton Spl)

Zonisade-carton-spl (Zonisade Carton Spl)
Packaging label for ZONISADE (zonisamide) oral suspension, 100 mg/5 mL, manufactured by Azurity Pharmaceuticals, Inc. The label indicates a 150 mL bottle with instructions to shake well before use and for oral use only. It includes storage information, an NDC number 52652-8001-1, a barcode, and a pharmacist medication guide URL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.